Name: Pfizer’s COVID-19 vaccine 95% effective in final results, company to seek approval within days
Brand: marketwatch.com
SKU: marketwatch-com-344
Availability: OnlineOnly

critic

Pfizer’s COVID-19 vaccine 95% effective in final results, company to seek approval within days

preview

An experimental Covid-19 vaccine from Pfizer Inc. and BioNTech SE was 95% effective in final results from a pivotal study and is showing signs of being safe, key pieces of data as the companies prepare to ask health regulators to authorize use. Pfizerplans to seek authorization for the vaccine within days, the companies said Wednesday, leaving the shot on track to go into distribution by the end of the year if health regulators permit.Out of 170 adult volunteers in the nearly 44,000-subject trial who developed Covid-19 with at least one symptom, 162 received a placebo, while eight got the vaccine, Pfizer and BioNTech&nbsp; said. See: The resulting 95% effectiveness rate puts the shot’s performance on par with shingles and measles vaccines. It is also consistent with the vaccine’s showing in a peek last week at how it did in an analysis of the first 94 subjects to fall sick. Researchers haven’t found any serious safety issues, the companies said. The vaccine appeared to be well tolerated following a review of data from 8,000 study subjects, the companies said. Popular on WSJ.com:Tesla Inc. stock continues to surge on news of an S&amp;P 500 inclusion, but the sheer size of the Silicon Valley electric-car maker adds complexity to the addition.

An experimental Covid-19 vaccine from Pfizer Inc. and BioNTech SE was 95% effective in final results from a pivotal study and is showing signs of being safe, key pieces of data as the companies prepare to ask health regulators to authorize use. Pfizerplans to seek authorization for the vaccine within days, the companies said Wednesday, leaving the shot on track to go into distribution by the end of the year if health regulators permit.Out of 170 adult volunteers in the nearly 44,000-subject trial who developed Covid-19 with at least one symptom, 162 received a placebo, while eight got the...

public

Pharma for @WSJ but I also once interviewed John Oates. jared.hopkins@wsj.com http://jaredshopkins.com

Jared S. Hopkins

MarketWatch is a website that provides financial information, business news, analysis, and stock market data. Along with The Wall Street Journal and Barron's, it is a subsidiary of Dow Jones & Company, a property of News Corp. Notable contributors include Mark Hulbert and Francine McKenna.

marketwatch.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Pfizer’s COVID-19 vaccine 95% effective in final results, company to seek approval within days

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS